WILSON GLYNN bought CVKD
January 18, 2024 · Form 4 insider transaction
WILSON GLYNN bought 70,000 shares of Cadrenal Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
70,000
Price
$0.00
Total value
N/A
InsiderWILSON GLYNN
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateJanuary 18, 2024
Filing dateJanuary 19, 2024
Shares owned after70,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2024 and vesting fully on January 18, 2025.